1. Home
  2. SB vs OABI Comparison

SB vs OABI Comparison

Compare SB & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Safe Bulkers Inc ($0.001 par value)

SB

Safe Bulkers Inc ($0.001 par value)

SELL

Current Price

$8.64

Market Cap

773.9M

ML Signal

SELL

Logo OmniAb Inc.

OABI

OmniAb Inc.

SELL

Current Price

$4.80

Market Cap

696.4M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
SB
OABI
Founded
2007
2012
Country
Monaco
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
773.9M
696.4M
IPO Year
2008
2021

Fundamental Metrics

Financial Performance
Metric
SB
OABI
Price
$8.64
$4.80
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
7
Target Price
★ $9.50
$8.33
AVG Volume (30 Days)
★ 1.4M
1.2M
Earning Date
11-24-2026
11-03-2026
Dividend Yield
★ 2.81%
N/A
EPS Growth
N/A
★ 6.56
EPS
★ N/A
N/A
Revenue
N/A
★ $18,666,000.00
Revenue This Year
$16.80
$87.73
Revenue Next Year
N/A
$25.31
P/E Ratio
$16.77
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$4.15
$1.32
52 Week High
$9.31
$5.43

Technical Indicators

Market Signals
Indicator
SB
OABI
Relative Strength Index (RSI) 52.08 56.11
Support Level $8.02 $1.93
Resistance Level $9.19 $5.06
Average True Range (ATR) 0.27 0.33
MACD -0.02 -0.04
Stochastic Oscillator 64.97 67.26

Price Performance

Historical Comparison
SB
OABI

About SB Safe Bulkers Inc ($0.001 par value)

Safe Bulkers Inc is an international provider of marine drybulk transportation services, transporting bulk cargoes, particularly coal, grain, and iron ore, along international shipping routes for consumers of marine drybulk transportation services. The company employs its vessels on both period time charters and spot time charters, according to the assessment of market conditions, with consumers of marine drybulk transportation services. The company generates almost all of its revenue from Time Charters.

About OABI OmniAb Inc.

OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.

Share on Social Networks: